<div id="readability-page-1"><p>Texas Yale Capital Corp. grew its position in shares of  UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 161.7% during the 2nd quarter, according to the company in its most recent filing with the Securities &amp; Exchange Commission. The institutional investor  owned 6,587 shares of the healthcare conglomerate's stock after buying an additional 4,070 shares during the quarter. Texas Yale Capital Corp.'s holdings in UnitedHealth Group were worth $2,055,000 as of its most recent filing with the Securities &amp; Exchange Commission.</p><div><p><span></span><span>Get <strong>UnitedHealth Group</strong> alerts:</span></p></div><ul><li>Snowflake Stock Is on Fire—It’s Still Not Too Late to Buy</li></ul><p>Other hedge funds and other institutional investors have also bought and sold shares of the company. Vanguard Group Inc. boosted its holdings in shares of  UnitedHealth Group by 6.6% in the 1st quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate's stock worth $47,519,620,000 after buying an additional 5,583,343 shares during the last quarter.  Wellington Management Group LLP grew its position in shares of  UnitedHealth Group by 10.6% during the 1st quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate's stock valued at $13,537,859,000 after acquiring an additional 2,486,839 shares during the period.  Nuveen LLC bought a new stake in shares of  UnitedHealth Group in the 1st quarter worth approximately $3,846,764,000.  Charles Schwab Investment Management Inc. increased its position in  UnitedHealth Group by 13.6% in the first quarter. Charles Schwab Investment Management Inc. now owns 7,070,385 shares of the healthcare conglomerate's stock worth $3,702,736,000 after buying an additional 847,054 shares during the last quarter.  Finally, Deutsche Bank AG lifted its position in shares of  UnitedHealth Group by 2.0% during the 1st quarter. Deutsche Bank AG now owns 5,386,274 shares of the healthcare conglomerate's stock valued at $2,821,061,000 after buying an additional 103,160 shares during the last quarter. Hedge funds and other institutional investors own  87.86% of the company's stock. </p><h2>Wall Street Analysts Forecast Growth</h2><p>Several research firms have commented on UNH. Wells Fargo &amp; Company upped their price objective on shares of UnitedHealth Group from $267.00 to $400.00 and gave the company an &#34;overweight&#34; rating in a report on Tuesday, October 7th. The Goldman Sachs Group started coverage on shares of UnitedHealth Group in a report on Tuesday, October 14th. They issued a &#34;buy&#34; rating and a $406.00 price objective for the company. Mizuho increased their target price on UnitedHealth Group from $300.00 to $430.00 and gave the stock an &#34;outperform&#34; rating in a research report on Thursday, October 9th. Cantor Fitzgerald  reiterated an &#34;overweight&#34; rating and set a $440.00 price objective on shares of UnitedHealth Group in a research note on Tuesday, August 26th. Finally, Deutsche Bank Aktiengesellschaft lowered UnitedHealth Group from a &#34;buy&#34; rating to a &#34;hold&#34; rating and set a $333.00 target price for the company. in a report on Wednesday, October 29th. Eighteen investment analysts have rated the stock with a Buy rating, nine have issued  a Hold rating and three have given a Sell rating to the company's stock. Based on data from MarketBeat.com, the stock currently has an average rating of &#34;Moderate Buy&#34; and an average price target of $397.12.</p><ul><li>UnitedHealth Group’s Recovery in Full Swing: Buy While It's Down</li></ul><p><b>Read Our Latest Analysis on UNH</b></p><h2>UnitedHealth Group Stock Performance</h2><p>Shares of UNH opened at $324.29 on Friday. The stock has a 50-day moving average price of $345.84 and a 200-day moving average price of $323.37. The company has a market cap of $293.75 billion, a PE ratio of 16.93, a price-to-earnings-growth ratio of 2.28 and a beta of 0.47. The company has a current ratio of 0.82, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71. UnitedHealth Group Incorporated has a 12-month low of $234.60 and a 12-month high of $630.73. </p><ul><li>Big Banks Are Setting the Tone as Earnings Season Kicks Off</li></ul><p>UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.87 by $0.05. The business had revenue of $113.16 billion during the quarter, compared to analyst estimates of $113.19 billion. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. UnitedHealth Group's revenue for the quarter was up 12.2% on a year-over-year basis. During the same period in the previous year, the business posted $7.15 earnings per share.  As a group, equities analysts forecast that  UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year. </p><h2>UnitedHealth Group Announces Dividend</h2><p>The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 16th. Shareholders of record on Monday, December 8th will be paid a dividend of $2.21 per share. The ex-dividend date of this dividend is Monday, December 8th. This represents a $8.84 annualized dividend and a yield of 2.7%. UnitedHealth Group's payout ratio is 46.14%. </p><h2>UnitedHealth Group Profile</h2> (Free Report)<p>UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.</p><h2>Recommended Stories</h2><ul><li>Five stocks we like better than UnitedHealth Group</li><li>Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index</li><li>OpenAI's Restructuring Sets up What Could Be the Biggest IPO Ever</li><li>What is a Microcap Stock? Everything You Need to Know </li><li>2 Rare Earth Stocks the U.S. Government Doesn’t Want to Fail</li><li>Stock Analyst Ratings and Canadian Analyst Ratings</li><li>CrowdStrike Partners With CoreWeave But Investors Sell the News</li></ul><p><strong>Want to see what other hedge funds are holding UNH?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).</p><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVVOSA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVVOSA"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in UnitedHealth Group Right Now?</h2><p>Before you consider UnitedHealth Group, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.</p><p>While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

<p>Texas Yale Capital Corp. increased its holdings in UnitedHealth Group (NYSE:UNH) by 161.7% in Q2, owning 6,587 shares valued at $2,055,000. Other institutional investors, including Vanguard and Wellington Management, also boosted their stakes. Analysts have raised price targets for UNH, with an average target of $397.12. The stock opened at $324.29, with a market cap of $293.75 billion and a PE ratio of 16.93. UnitedHealth reported Q3 earnings of $2.92 per share, exceeding estimates, with revenue of $113.16 billion, up 12.2% year-over-year.</p>

Texas Yale Capital Corp. Grows Holdings in UnitedHealth Group Incorporated $UNH